1_hpv_vaccine

COVID-19 puts more than 117 million children at risk of missing out on measles vaccines

April 15, 2020
Research and Development MMR vaccines, anti vaxx, anti-vaxx, anti-vaxxers, measles

Measles immunisation campaigns in 24 countries have been delayed due to COVID-19, threatening the vaccinations of 117 million Children. The …

shutterstock

Sanofi and GSK set aside rivalry with “unprecedented” COVID-19 vaccine partnership

April 15, 2020
Research and Development COVID-19, GSK, Sanofi, coronavirus

Usual rivals Sanofi and GlaxoSmithKline have said they are to put aside competition with the forging of a new “unprecedented …

US to suspend funding of the World Health Organization amidst review

April 15, 2020
Research and Development COVID, COVID-19, coronavirus

US President Donald Trump has announced the US will stop funding the World Health Organization due to allegations that they …

bristolll

Judge increases the amount of damages Gilead owes Bristol-Myers Squibb in CAR-T legal dispute

April 14, 2020
Manufacturing and Production Bristol-Myers Squibb, Gilead, bristol myers squibb

A judge has ruled that Gilead Sciences owe Bristol-Myers Squibb (BMS) additional funds after infringing on one of the company’s …

Patient Experience: Living with type 1 diabetes

April 14, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, diabetes, feature, patient experience

23-year-old US student Madelyn Lazra recently graduated with a BA in Business Law and certification in International Business, and is …

astrazeneca_building_white

AstraZeneca to pit blood cancer drug Calquence against COVID-19 with the company’s fastest-ever trial launch

April 14, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Calquence, coronavirus, pharma

As the R&D race against COVID-19 continues, AstraZeneca is poised to launch a global, multicentre clinical trial to test its …

phone

UK to go ahead with COVID-19 contact-tracing app

April 14, 2020
Manufacturing and Production

The British government has confirmed it will go ahead in utilizing an app that will warn people if they have …

gilead-sciences

Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients

April 14, 2020
Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …

0_chlororor

Fatal heart complications halt Brazilian study of chloroquine in treating COVID-19

April 14, 2020
Manufacturing and Production COVID-19, chloroquine, hydroxychloroquine

A chloroquine study investigating its effects in treating the COVID-19 coronavirus in Brazil has been postponed for safety reasons. It …

cdc_coronavirus_0

Pharmafile.com’s weekly COVID-19 news round-up

April 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in …

dr_molk

Seres Therapeutics appoints Dr Lisa von Moltke as new Chief Medical Officer

April 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Lisa von Moltke has left Aklermes and has joined Seres Therapeutics as its new Chief Medical Officer. Chief Executive …

shutterstock_138095450

Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement

April 9, 2020
Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory

Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …

viagra_tablette

Pfizer and Eli Lilly defeat lawsuit over claims Viagra and Cialis cause cancer

April 9, 2020
Business Services Pfizer, viagra

Pfizer and Eli Lilly have defeated a class action lawsuit seeking billions in damages over claims that Viagra and Cialis …

hydoxyyy

US reports increase in Hydroxychloroquine misuse

April 9, 2020
Business Services COVID-19, Donald Trump, coronavirus, hydroxychloroquine

The American Association of Poison Control Centers (AAPCC) has said there has been an increase in people abusing the anti-malaria …

shutterstock_273326141

Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics

April 9, 2020
Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma

Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …

90ten_team_photo

Envision Pharma Group acquires healthcare comms consultancy 90TEN

April 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Envision Pharma Group, pharma

Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …

mcintyre-headshot

Dr Maritza McIntyre appointed Chief Development Officer at StrideBio

April 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer. The newly created role will …

sage_logo

Sage Therapeutics to halve its total workforce in radical cost-cutting move

April 8, 2020
Research and Development, Sales and Marketing Sage Therapeutics, pharma, staff cuts

Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy …

000_cdcdc

COVID-19 less severe in paediatric patients, according to the CDC

April 8, 2020
Research and Development COVID-19, coronavirus

The Centers for Disease Control and Prevention (CDC) confirms that COVID-19 is less severe in children than adults. The report, …

insulin

Eli Lilly will limit insulin costs to $35 per month for patients in the US due to COVID-19

April 8, 2020
Research and Development Eli Lilly, diabetes, insulin

Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the …

The Gateway to Local Adoption Series

Latest content